Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis.
about
Treatment for lupus nephritisTreatment for lupus nephritisHematopoietic stem cell transplantation for auto immune rheumatic diseasesRole of immunosuppressive therapy for the treatment of multiple sclerosisA treatment algorithm for children with lupus nephritis to prevent developing renal failureLong-term data on corticosteroids and mycophenolate mofetil treatment in lupus nephritis.Incidence and prevention of bladder toxicity from cyclophosphamide in the treatment of rheumatic diseases: a data-driven review.An adult case of severe steroid-resistant Henoch-Schönlein purpura nephritis treated with intravenous cyclophosphamide and tonsillectomyUmbilical cord mesenchymal stem cell transplantation in active and refractory systemic lupus erythematosus: a multicenter clinical studyRecent advances in the understanding of renal inflammation and fibrosis in lupus nephritis.Pin1-Targeted Therapy for Systemic Lupus ErythematosusRecent clinical trials in lupus nephritis.Cyclophosphamide and lupus nephritis: when, how, for how long?Efficacy of long-term maintenance therapy with mycophenolate mofetil in lupus nephritis.Mycophenolate mofetil as maintenance therapy for proliferative lupus nephritis: a long-term observational prospective study.Current concepts for the management of systemic lupus erythematosus in adults: a therapeutic challengeMesenchymal stem cells for the treatment of systemic lupus erythematosus: is the cure for connective tissue diseases within connective tissue?Paradoxical effects of all-trans-retinoic acid on lupus-like disease in the MRL/lpr mouse model.Treatment of severe proliferative lupus nephritis: the current state.Lupus nephritis: current issues.EULAR randomised controlled trial of pulse cyclophosphamide and methylprednisolone versus continuous cyclophosphamide and prednisolone followed by azathioprine and prednisolone in lupus nephritis.Bone loss in patients treated with pulses of methylprednisolone is not negligible: a short term prospective observational study.IgG immunoadsorption reduces systemic lupus erythematosus activity and proteinuria: a long term observational study.Safety and efficacy of intravenous pulse cyclophosphamide in acute steroid refractory inflammatory bowel disease.Pulse cyclophosphamide therapy in the management of patients with macular serpiginous choroidopathy.Aspergillus-associated cerebral aneurysm successfully treated by endovascular and surgical intervention with voriconazole in lupus nephritis patient.Cyclophosphamide: new approaches for systemic lupus erythematosus.Lessons learned from anti-CD40L treatment in systemic lupus erythematosus patients.Randomized controlled trials in systemic lupus erythematosus: what has been done and what do we need to do?Ovarian failure in systemic lupus erythematosus patients treated with pulsed intravenous cyclophosphamide.Treatment of lupus nephritis with abatacept: the Abatacept and Cyclophosphamide Combination Efficacy and Safety Study.Understanding lupus nephritis: diagnosis, management, and treatment options.Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow TransplantationPrognostic factors in lupus nephritis.Cyclophosphamide in lupus nephritis.Lupus nephritis: induction therapy.American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritisBlood stem cells as therapy for severe lupus.Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis.Basic immunosuppressive drugs outside solid organ transplantation.
P2860
Q24202572-1B530DDD-1601-45CB-8FFE-95785362C9E0Q24247408-0334F29E-5312-4DD6-B880-19FE81C70079Q26751425-1668DD94-3AA6-4F26-A6D6-3E442E63D387Q26827467-D0F90E72-0B36-465F-9596-3863DE7E84BEQ27026880-6F953E59-4BAB-4385-ADD6-FC932A18915BQ30577281-E01723CE-5771-4098-A583-F1D9ADD6E48AQ33521057-33394D66-0581-4115-8AD9-DE33C95DF9FCQ33622282-33AB6283-4B6B-4EF3-8E73-4C887F93C690Q33767123-CE0BD6E1-9198-47D8-863A-F077345C1C93Q33806541-38A05AD3-9DD4-4459-8026-E9404963E730Q33859906-33A05830-EDA8-4C43-8CC1-3770BFD21D1FQ33924437-7434C4BA-1B7F-48C9-B730-9FB2AA6B03A3Q34095231-14E73049-3C8B-4A7F-860F-2ECF168F29A9Q34490782-C6C2473D-3A5C-40E6-9074-04548E7C2C03Q34613945-0084F892-D46C-4EA1-B65F-9D2BB111109BQ34988089-5F25FF1E-F731-45A8-AAB6-9AF8B92A56CCQ35155191-31D3692F-CEEF-4B28-AA23-F2ADA3432CC0Q35182476-4CF0CC17-CCE7-4555-93B6-93CA33472DC7Q35201234-BE14E55B-EFC9-4BC5-B267-46E0B47B3669Q35553102-61F0A18E-1E15-49E7-82C0-7D9D3CA3F9F8Q35554126-32976AED-0EB0-4501-89BD-9EE370E6DE7EQ35554374-E0CF2C52-01A5-4DC0-ABE1-1187E838DC6FQ35555714-A195C0B3-624D-4120-B756-A04BB3DF9207Q35595464-B02444A1-A25C-4706-BE9B-B625785FB6F0Q35722478-3A9F78C4-92EE-4270-A2A0-41144A3039E6Q35778456-5AA8005D-2505-41E1-84F2-8148A3D295BDQ35824515-1A557DF4-0060-4B07-B80D-C552F1DC4925Q35824531-DE885E0A-9D97-4F10-BC02-2F7AE9437D4BQ35824537-610FF614-EE5F-4265-9159-708329066D0CQ35918369-E346A749-A1D3-46DC-B193-6F233BF5B339Q35927877-34B41C53-CBB7-4714-B2E5-F30412FEE3D4Q36008840-D5692FBF-9AA5-48A5-834A-5ACBC1F5F9E6Q36020897-DF9C8F2E-4AC2-4795-9B20-A411F39ABFACQ36054839-3654BCED-2986-4972-8CF9-3968329A6D30Q36054857-905AA8F5-BF95-49DB-A783-B10C462960FDQ36085856-65E5A440-AE2C-417E-9A9B-0FE8CF3A467EQ36221407-1C421C90-7C54-46AD-B43C-8DDBAB0C16B6Q36239643-7CA78075-7101-41E1-8841-F4D3C2B1442CQ36302245-45E97D22-4B41-4706-A93B-139040FEB635Q36407314-5F39C92D-21A1-4CAD-92C1-38785675E274
P2860
Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Combination therapy with pulse ...... patients with lupus nephritis.
@en
Combination therapy with pulse ...... patients with lupus nephritis.
@nl
type
label
Combination therapy with pulse ...... patients with lupus nephritis.
@en
Combination therapy with pulse ...... patients with lupus nephritis.
@nl
prefLabel
Combination therapy with pulse ...... patients with lupus nephritis.
@en
Combination therapy with pulse ...... patients with lupus nephritis.
@nl
P2093
P1476
Combination therapy with pulse ...... patients with lupus nephritis.
@en
P2093
Boumpas DT
Danning CL
Gourley MF
Klippel JH
P304
P356
10.7326/0003-4819-135-4-200108210-00009
P407
P577
2001-08-01T00:00:00Z